Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.
Anju MurayamaSae KamamotoHiroaki SaitoKohki YamadaDivya BhandariIori ShojiHanano MamadaMoe KawashimaErika YamashitaEiji KusumiToyoaki SawanoBinaya SapkotaTetsuya TanimotoAkihhiko OzakiPublished in: International journal of environmental research and public health (2022)
There were substantial financial relationships between pharmaceutical companies and board-certified infectious disease specialists in Japan. Furthermore, high ranked specialists such as those in the executive board had stronger financial ties with the companies.